Two protocols were used: one where AcSDKP was administered alone either by injection or continuous infusion before DOX, and another where six subcutaneous injections of AcSDKP were administered starting 48 hours before DOX, followed by G-CSF treatment from day 3 to day 6 post-DOX
Ingredients reduced L-glutathione from fermentation, bulking agent: rice flour, hydroxypropylmethylcellulose* * capsule shell Made in Germany Raw material from a non-EU country Important information: Food supplements should not be used as a substitute for a varied and balanced diet and a healthy lifestyle
The combination is commonly compounded as a serum in the following strengths: Tranexamic Acid/Niacinamide/Kojic Acid 3/5/1%
Research suggests it has a relatively mild safety profile, but long-term safety studies are still limited
Collagen and Bone Morphogenetic Proteins (BMPs) : Preliminary research indicates that BPC 157 may influence the activity of collagen fragments associated with bone morphogenetic proteins (BMPs), which are important for the formation and remodeling of tissues such as bone and cartilage